Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) was the target of a significant increase in short interest in September. As of September 15th, there was short interest totaling 111,907 shares, an increase of 1,048.7% from the August 31st total of 9,742 shares. Based on an average trading volume of 81,381 shares, the short-interest ratio is presently 1.4 days.
Ono Pharmaceutical Price Performance
OPHLY stock opened at $5.14 on Friday. The company’s 50-day moving average price is $5.04 and its 200 day moving average price is $4.99. Ono Pharmaceutical has a 52 week low of $3.71 and a 52 week high of $5.75.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd. is a Japan-based research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its principal focus areas include oncology, immunology, neurology and other specialty diseases, with an emphasis on innovative treatments for conditions with significant unmet medical needs.
The company is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used in the treatment of multiple types of cancer.
Featured Articles
- Five stocks we like better than Ono Pharmaceutical
- Dave’s Success Has Investors Split
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
